Related Experiment Video
Updated: Feb 2, 2026
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Efficacy of a self-management education programme on patients with type 2 diabetes in primary care: A randomised
Estibaliz Gamboa Moreno1, Maider Mateo-Abad2, Lourdes Ochoa de Retana García3
1Osakidetza, Active Patient Programme, Gros Health Centre, Avda Navarra 14, 20013 San Sebastián, Spain; Kronikgune-Research Centre on Chronicity, Torre del BEC, Ronda de Azkue, 1, 48902 Barakaldo, Bizkaia, Spain; Biodonostia Health Research Institute, Paseo Doctor Begiristain, 20014 San Sebastián, Spain.
Aim:
The purpose of this study was to assess the efficacy of the Spanish Diabetes Self-Management Program (SDSMP) versus usual care in adults with type 2 diabetes mellitus (T2DM) residing in a Spanish region.
Methods:
A two-year follow-up randomised controlled trial. The intervention consisted of 6 weekly structured peer-to-peer workshops. The primary outcome was change in HbA1c levels. Secondary outcomes included other clinical measures, quality of life, self-efficacy, life-style changes, medication and use of healthcare services. Mixed effect models were fitted.
Results:
n=297 patients were recruited in each study arm. Baseline HbA1c levels were comparable in both groups with an overall mean 7.1 (SD=1.2). The intervention did not significantly modify HbA1c, or other cardiovascular variables. Significant improvements were seen in self-efficacy, and in particularly its disease control component. Certain differences were also observed in the use of healthcare resources and medication consumption. High workshop participation and satisfaction rates were achieved.
Conclusion:
HbA1c reductions are difficult to obtain in adequately controlled patients. On the other hand, raising awareness on one's disease can increase disease control self-efficacy. This finding, accompanied by reduced medication consumption and healthcare use rates, highlights that usual care would be benefited by incorporating certain SDSMP aspects.
Trial Registration:
ClinicalTrials.gov identifier NCT01642394.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:13Patient-centered Care
01:18Types of Records II: Educational and Administrative Records
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...